Quick Answer
Whitehawk Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $37.57 million for the year ending 2025.
- Whitehawk Therapeutics, Inc. showed an increase of +31.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Whitehawk Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2007 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $37.57 million | Fiscal year 2024: $28.67 million | Fiscal year 2023: $62.89 million | Fiscal year 2022: $39.02 million | Fiscal year 2021: $148.99 million | Fiscal year 2020: $4.46 million | Fiscal year 2019: $38.52 million | Fiscal year 2018: $62.61 million | Fiscal year 2017: $20.26 million | Fiscal year 2016: $1.61 million | Fiscal year 2015: $5.14 million | Fiscal year 2015: $6.3 thousand | Fiscal year 2014: $5.3 thousand | Fiscal year 2013: $6.3 thousand | Fiscal year 2012: $4.6 thousand | Fiscal year 2012: $5.4 thousand | Fiscal year 2011: $4.1 thousand | Fiscal year 2011: $6.1 thousand | Fiscal year 2010: $26.9 thousand | Fiscal year 2009: $11.1 thousand | Fiscal year 2007: $0.00 | Fiscal year 2007: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: